Delivery Order SPE2DB22D2006-SPE2DB25FW4EL
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,259.36 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $1,723.61 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL. This firm fixed-price, non-set-aside contract was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,156.57 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL, a testosterone replacement therapy medication. This non-competitive, firm fixed-price delivery order was awarded on September 4, 2025, with an ultimate completion date of September 5, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,076.62 firm fixed price delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL, with an ultimate completion date of September 12, 2025. This non-set-aside contract represents a single delivery order fulfilling pharmaceutical supply needs for federal medical procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the Defense Logistics Agency's Medical Supply Chain...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,569.66 for Testosterone Cypionate 200 mg/mL on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of pharmaceutical supply services to support federal medical procurement needs. The contract was not issued under any set-aside program and will be performed at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL with a ceiling value of $1,586.61. This firm fixed-price delivery order, issued on September 11, 2025, is expected to be completed by September 12, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and is a major pharmaceutical distributor providing critical medical...
- The Defense Logistics Agency awarded a $1,416 delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order, awarded September 12, 2025, represents a non-competitive set-aside transaction and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $1,925.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL on April 22, 2025, with completion targeted for April 23, 2025. This is a competitively awarded, non-set-aside contract with performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a Delivery Order valued at $1,019.16 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL on April 22, 2025, with an ultimate completion date of April 23, 2025. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency (DLA) awarded a $1,713.12 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Testosterone Cypionate 2,000 mg/10mL vials. This competitively awarded, non-set-aside contract features firm fixed pricing and a delivery completion date of August 6, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a single transaction under the company's broader...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW4ELDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,228.04 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL, a hormone replacement therapy medication. This firm fixed-price delivery order, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a non-competed award under the company's existing contract vehicle. Performance will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's comprehensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a global pharmaceutical support vehicle for military healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen maintains an extensive portfolio of federal contracts covering a wide spectrum of medications and medical supplies essential to Defense Health Agency operations and broader federal medical procurement needs. The delivery order reflects the company's ongoing role as a critical vendor for specialty pharmaceutical products supporting military personnel and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 9/12/25 |